Katherine A. Eade
Known title: DirectorCIK: 0001721318
Associated companies
Transaction History
| HBIO | ▲ Buy | Grant | 16,556 | $0 | 6/9/2026 | View on chart |
| HBIO | ▲ Buy | Grant | 110,000 | $0 | 7/16/2025 | View on chart |
| HBIO | ▲ Buy | Grant | 45,872 | $0 | 5/21/2024 | View on chart |
| HBIO | ▲ Buy | Grant | 25,554 | $0 | 5/22/2023 | View on chart |
| HBIO | ▲ Buy | Grant | 38,259 | $0 | 5/24/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 2,525 | $0 | 1/1/2022 | View on chart |
| HBIO | ▲ Buy | Grant | 1,401 | $0 | 12/28/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Harvard Bioscience Forms Scientific Advisory Board
Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.
Harvard Bioscience Forms Scientific Advisory Board. Harvard Bioscience announced the creation of a Scientific Advisory Board. This move is intended to support the company's scientific direction and product development. The stock is currently trading with a high beta, indicating higher volatility relative to the broader market.